1. OP037 Risk of cancer in inflammatory bowel disease patients is associated with age and recent use of immunomodulators, while biologics and aminosalicylates are protective factors: a cross-sectional and follow-up analysis of the Swiss IBD cohort study. (16th January 2018) Authors: Greuther, T; Scharl, S; Barthel, C; Rossel, J -B; Biedermann, L; Misselwitz, B; Vavricka, S; Rogler, G; Scharl, M Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S026 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗